Celltrion, 328,293 Shares Net Sold by Foreigners in Last 5 Days... Stock Price at 302,000 Won (-1.47%)

As of 12:30 PM on the 5th, Celltrion is trading at 302,000 KRW, down 1.47% from the previous day. The trading volume is 269,706 shares, which is about 35.63% of the previous day's volume. Celltrion is known as a protein and biopharmaceutical manufacturing company.

On March 3rd, Minjeong Seon, a researcher at Hana Financial Investment, stated, "EMA in Europe has initiated a Rolling Review for Regkirona. If Regkirona is marketed in the US or European markets, Celltrion is expected to see a significant increase in performance this year. Ultimately, if it succeeds in entering the US or European markets where the number of patients is large and drug prices are set high, the sales of Regkirona are expected to be on a scale incomparable to existing biosimilars." She set Celltrion's target price at 390,000 KRW.

Over the past five days, individual investors have net purchased 151,927 shares of Celltrion, while foreigners and institutions have net sold 328,293 shares and net purchased 170,188 shares, respectively.

※ Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.